IIPR and Cannabis Reform: 280E Relief and Schedule III Upside – April 16, 2026
Schedule III cannabis reclassification could transform federal policy by easing research restrictions and providing 280e tax relief. This change may improve clinical access and reduce costs for medical cannabis businesses. Patients and clinicians should…
Wildings in Newport: From Grand Store to Illicit Cannabis Farm
Illicit cannabis farm safety risks are significant in Newport, Wales, where a grand department store was converted into an unregulated cannabis cultivation site. These illicit operations lack quality control and pose contamination dangers. Patients must…
Cannabis Europa Conference Highlights European Market Surge
European cannabis market consolidation is accelerating growth and regulatory clarity. Cannabis Europa's London event highlights this surge in medical cannabis development. Clinicians should watch for improved product standardization and clinical research.
More than 350 Cannabis Plants Seized in Kalgoorlie Home
Cannabis law enforcement actions in Kalgoorlie underscore the disconnect between regulatory frameworks and patient access to medicinal cannabis. Over 350 cannabis plants were seized from a residential property, illustrating enforcement under current…
CBD Gummies for Lung Issues: What the Evidence Shows and How They Fit Into Daily Wellness
Patients often inquire about cbd gummies lung issues evidence, but current clinical data is limited. Understanding what the evidence shows is crucial for safe use. This article reviews the scientific findings and their implications for daily wellness.
Dog CBD Anxiety Gummies: What Pet Owners Need to Know Before Trying Them
Veterinary CBD anxiety research is an emerging field with limited clinical data. Pet owners increasingly seek CBD gummies for dog anxiety despite regulatory challenges. Understanding safety and dosing is essential before trying these products.
What THC Products Are Legal in Texas? Gummies and Drinks Explained
Texas hemp THC regulations create a complex legal landscape for gummies and drinks. Understanding these rules is essential for patient safety and clinical guidance. This article explains the legality and safety considerations of hemp-derived THC products…
Cannabis Sales Plummet as Regulators Crack Down on Booming Industry
Cannabis market disruption is intensifying as regulators crack down on the booming industry. This enforcement affects patient access to therapeutic cannabis and treatment continuity. Clinicians must understand these changes to support patient care…
Young Americans need to travel abroad to learn what our generation had to deal with to get barely 3gs
“My parents walked uphill both ways in a blizzard just to find a consistent supply.” Modern dispensary: “Would you like our third-party lab results, potency analysis, and a loyalty card with your order?” Via r/trees Further…
She built a million-dollar cannabis facility on a reservation. Now she can’t grow there.
Tribal cannabis regulations create complex challenges for medical cannabis access. Regulatory uncertainty disrupts supply chains and patient access to consistent products. This impacts therapeutic management for patients relying on tribal cannabis…